Citi training test Study guides, Class notes & Summaries

CITI Training Test Questions with 100% Correct Answers | Verified | Latest Update

CITI training Test

Why are institutionally provisioned technology systems (in other words, systems provided through a university, hospital, or clinic) generally more secure than consumer products? - Because information technology professionals have vetted them with the vendor. When would an IRB consider the risks of a study to be controlled? - When there is an appropriate risk mitigation and management plan in place. What existing federal regulations define technology-based risk assessment? - None of the abov...

Why are institutionally provisioned technology systems (in other words, systems provided through a university, hospital, or clinic) generally more secure than consumer products? - Because information technology professionals have vetted them with the vendor. When would an IRB consider the risks of a study to be controlled? - When there is an appropriate risk mitigation and management plan in place. What existing federal regulations define technology-based risk assessment? - None of the abov...

CITI training Test

CITI Training test questions with correct answers

CITI training Test

A subject participates in a drug study because treatment is available at no or reduced cost, and he could not otherwise afford it. This is an example of A. Institutional vulnerability B. Communicative vulnerability C. Economic vulnerability D. Social vulnerability - C. Economic vulnerability According to the authors, there are four common abuses that historically are described as giving rise to vulnerability . Which response below contains the correct four? A. Coercion, undue influence, ...

CITI Training and Belmont report Test Questions and Answers (2023/2024)CITI Training and Belmont report Test Questions and Answers (2023/2024)CITI Training and Belmont report Test Questions and Answers (2023/2024)

What must you file before conducting human clinical trials with an experimental drug? - IND application (Form FDA 1571) During the clinical development phase of the IND process, what must sponsors do? - Maintain current IND application by amending IND with new Form FDA 1571 and providing FDA with: safety updates copies of new protocols FDA 1572 Annual Progress reports this document notifies FDA of relevant changes in investigators conducting clinical trials under the IND. - Form FDA 15...